VBWG
Slides

RIO-Diabetes trial: Rimonabant In Obesity



RIO-Diabetes

Download VBWG06_RIO_Diabetes.ppt (13 slides - 0.7MB)

RIO-Diabetes RIO-Diabetes: Background and rationale RIO-Diabetes: Study design RIO-Diabetes: Baseline characteristics RIO-Diabetes: Baseline efficacy parameters RIO-Diabetes: Treatment effect on weight and waist circumference RIO-Diabetes: Treatment effect on cholesterol and triglycerides RIO-Diabetes: Treatment effect on glucose metabolism RIO-Diabetes: Treatment effects on secondary endpoints (summary) RIO-Diabetes: Safety and tolerability RIO-Diabetes: No significant effect on mood RIO-Diabetes: Summary RIO-Diabetes: Implications


DiabetesObesityRimonabantRIO

Related at vwbg.org

Managing CV Risk in Diabetes: Setting More Aggressive Goals to Meet a Growing Crisis

The evolving diabetes epidemic is raising concern over the adverse long-term effect on cardiovascular (CV) disease.

ADOPT: A Diabetes Outcome Progression Trial

View/Download individual slides (15 Slides)

Diabetes REduction Assessment with ramipril and rosiglitazone Medication (DREAM) trial

View/Download individual slides (22 Slides)
More related